# Pluses and minuses of the weight-loss drug bonanza

Page: https://stenobird.com/podcast/the-big-view-6037663/pluses-and-minuses-of-the-weight-loss-drug-bonanza
Text version: https://stenobird.com/podcast/the-big-view-6037663/pluses-and-minuses-of-the-weight-loss-drug-bonanza.md
Podcast: [The Big View](https://stenobird.com/podcast/the-big-view-6037663)
Published: 2025-11-18T04:27:00+00:00
Episode link: https://pdst.fm/e/traffic.megaphone.fm/THRH2737040369.mp3
Audio file: https://pdst.fm/e/traffic.megaphone.fm/THRH2737040369.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-big-view-6037663/episodes/pluses-and-minuses-of-the-weight-loss-drug-bonanza
Duration seconds: 2061

## Resource

Obesity treatments made by Novo Nordisk and Eli Lilly have spawned a healthcare revolution, with sales set to hit $150 bln by 2031. In this episode of The Big View, Peter Thal Larsen talks to Breakingviews Associate Editor Aimee Donnellan about their origins – and their impact. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-big-view-6037663/episodes/pluses-and-minuses-of-the-weight-loss-drug-bonanza/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-big-view-6037663/pluses-and-minuses-of-the-weight-loss-drug-bonanza.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.